Literature DB >> 7142154

Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activity.

D A Eppstein, Y V March, B B Schryver, M A Larsen, J W Barnett, J P Verheyden, E J Prisbe.   

Abstract

Analogs of (A2'p)2A core and ppp(A2'p)2A were chemically synthesized and their susceptibility to phosphodiesterase degradation and ability to either activate an endonuclease or to inhibit cell growth were determined. The absence of the internal 3'-OH groups ((3'dA2'p)2A) resulted in a 5-fold increase in stability, but also in a 10-fold decrease in activity, as measured by (a) activation of an endonuclease in cell-free extracts and inhibition of protein synthesis in intact cells by the 5'-triphosphate species and (b) inhibition of DNA synthesis in synchronized cells by the core analogs. An uncharged derivative of this analog containing two methylphosphotriesters, although significantly more stable, was even less active. Additional deletion of the terminal 3'-OH ((3'd A2'p)23'dA) resulted in a further 6-fold increase in stability (30-fold overall increase in stability), as well as approximately a 2-fold increase in ability to inhibit cell growth, as compared to the natural 2'5' A core. The analog lacking a terminal 2'-OH as well as lacking the internal 3'-OH group ((3'dA2'p)22'dA) showed an overall 15-fold increased stability, yet showed very little activity in inhibiting cell growth. The most stable (120-fold increased overall stability) as well as most active analog was a xyloadenosine analog of 2'5' A core, (xyloA2'p)2xyloA. These results show that modification of the 3'-terminal OH appears to be most important in increasing 2'-5' A core stability as well as biological activity. However, the mechanism of cell growth inhibition by these 2'-5' A core analogs may involve pathways different from those utilized by the 2'-5' A-dependent endonuclease.

Mesh:

Substances:

Year:  1982        PMID: 7142154

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Influence of the xyloadenosine analogue of 2',5'-oligoriboadenylate on poly(A)-specific, 2',5'-oligoriboadenylate degrading 2',3'-exoribonuclease and further enzymes involved in poly(A)(+)mRNA metabolism.

Authors:  H C Schröder; G Gosselin; J L Imbach; W E Müller
Journal:  Mol Biol Rep       Date:  1984-12       Impact factor: 2.316

2.  pppA2'p5A' blocks vesicular stomatitis virus replication in intact cells.

Authors:  B Alarcon; H Bugany; L Carrasco
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

3.  Immunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotes.

Authors:  L Laurence; J Marti; D Roux; H Cailla
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Chemical synthesis and biological activities of analogues of 2',5'-oligoadenylates containing 8-substituted adenosine derivatives.

Authors:  M Kanou; H Ohomori; H Takaku; S Yokoyama; G Kawai; R J Suhadolnik; R Sobol
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

5.  Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.

Authors:  R W Sobol; R Charubala; W Pfleiderer; R J Suhadolnik
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

6.  Conformational analysis of the trinucleoside diphosphate 3'd(A2'-5'A2'-5'A). An NMR and CD study.

Authors:  J Doornbos; R Charubala; W Pfleiderer; C Altona
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

7.  Conformational characteristics of the trinucleoside diphosphate xyloA2'-5'xyloA2'-5'xyloA. A nuclear magnetic resonance and CD study.

Authors:  J Doornbos; G Gosselin; J L Imbach; C Altona
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

8.  Preparation of the individual diastereomers of adenylyl-(2'-5')-P-thioadenylyl-(2'-5')-adenosine and their 5'-phosphorylated derivatives.

Authors:  E de Vroom; A Fidder; C P Saris; G A van der Marel; J H van Boom
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

Review 9.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

10.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.